Gaurav Shah - 17 Aug 2023 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Role
CEO, Director
Signature
/s/ Martin Wilson, as attorney-in-fact for Gaurav Shah
Issuer symbol
RCKT
Transactions as of
17 Aug 2023
Net transactions value
-$73,750
Form type
4
Filing time
21 Aug 2023, 16:05:39 UTC
Previous filing
15 Aug 2023
Next filing
16 Nov 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RCKT Common Stock Sale $73,750 -4,767 -0.9% $15.47 524,854 17 Aug 2023 Direct F1
holding RCKT Common Stock 207,897 17 Aug 2023 By Spouse
holding RCKT Common Stock 198,341 17 Aug 2023 By Gaurav D. Shah Irrevocable Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person.